Inhibition of α4β1 integrin increases ovarian cancer response to carboplatinJennifer Scalici, Jill K. Slack‐Davis, Amir A. Jazaeri et al.|Gynecologic Oncology|2014Cited by 36
The promise of antiangiogenic therapy for ovarian cancerAmir A. Jazaeri, Jill K. Slack‐Davis|Cancer Biology & Therapy|2009Cited by 4
Abstract 945: Inhibition of T-type calcium channels sensitizes ovarian cancer cell growth and metastasis to platinum-based chemotherapy.Eli V. Casarez, Jill K. Slack‐Davis, Amir A. Jazaeri et al.|Cancer Research|2013Cited by 2